Navigation Links
Cubresa Launches Simultaneous PET/MRI Technology
Date:5/27/2015

Winnipeg, MB (PRWEB) May 27, 2015

Empowering biomedical researchers with richer, more comprehensive imaging data to combat disease, Cubresa Inc. today announced its MR Compatible Small Animal PET Scanner.

“Our MR Compatible in-bore PET Scanner uses silicon photomultiplier detector technology, so it can be inserted into single-purpose preclinical MRI machines from manufacturers like Bruker and Agilent,” said James Schellenberg, Founder of Cubresa, headquartered in Winnipeg, Canada. “This enables simultaneous PET and MRI data acquisition with the image quality researchers expect.”

With the new instrument, Schellenberg said researchers would be able to measure and correlate multiple physiological processes simultaneously with exceptional tissue contrast, quantitative accuracy and study throughput.

“Although multimodal scanners capable of simultaneous PET/MRI acquisition have been introduced in clinical medicine, commercially available small animal solutions have not yet seen adoption in preclinical studies. It’s time for that to change,” said Schellenberg.

Cubresa’s product is based on PET detector technology developed through a Canadian research collaboration led by Dr. Andrew Goertzen, Associate Professor of Radiology in the College of Medicine, Faculty of Health Sciences at the University of Manitoba. Earlier this year, first in vivo mouse imaging studies were obtained using a proof of concept system installed in Winnipeg.

“These images demonstrate our ability to acquire high resolution PET/MRI data simultaneously on a 7T Bruker scanner,” said Goertzen. “We are excited at the possibilities that this new in-bore PET scanner enables, including enhanced quantification through MRI guided partial volume correction and the ability to directly combine and correlate PET and MRI measures.”

“This is a prime example of the University’s ability to move technology from the lab to commercialization,” said Dr. Digvir Jayas, Vice-President (Research and International) at the University of Manitoba. “Our Transformational Partnerships approach enables effective collaboration with industry.”

Cubresa has also entered into a research agreement with the Lawson Health Research Institute of London, Ontario, which will be the first customer to receive the new scanner. Lawson will utilize the scanner for an extensive number of applications, including those in the areas of oncology, cardiology, neurodegenerative diseases, and PET probe development.

“Capturing multimodal images of the same anatomy at the same time with preclinical PET/MRI allows us to make new discoveries at a quicker pace, thus accelerating the translation to new clinical applications in precision medicine,” said Dr. Frank Prato, Imaging Program Leader and Assistant Scientific Director, Lawson Health Research Institute.

Cubresa will feature the in-bore PET Scanner, along with the previously released SPECT Imaging System, SPARK™, at the upcoming International Society for Magnetic Resonance in Medicine (ISMRM) meeting in Toronto and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Baltimore; both in June.

At ISMRM, Dr. Jonathan Thiessen of the Lawson Health Research Institute will deliver an oral presentation entitled ‘MRI Compatibility of a High-Resolution Small Animal PET Insert Operating Inside a 7T MRI’ summarizing performance data obtained using the Winnipeg system.

Read the full story at http://www.prweb.com/releases/2015/05/prweb12748473.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. Darrow Wealth Management Launches New Website
2. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
3. Elsevier Launches PracticeUpdate, a Free Information Portal for Physicians
4. Neogen launches rapid tests for ractopamine
5. Rockingham County Economic Development Launches New Website
6. BioHealth Innovation, Inc. Launches Program to Help Life Science Companies Navigate Federal Funding Application Process
7. Elsevier Launches Web-Based Pathway Studio and Adds New Molecular Data from Its Biology Journals to Boost Early Discovery Research
8. Dr. Richard Charmoy Launches Groundbreaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
9. CellHealth Institute Launches with Support from Influential Investors
10. Dr. Timothy Rauch of Albuquerque, New Mexico Launches a Groundbreaking Cavity Prevention Program
11. Neighborhood Smiles Launches a Groundbreaking Cavity Prevention Program for Their Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2020)... , ... September 01, 2020 , ... ... sciences, biotechnology, and diagnostics companies, has announced the placement of Julianne Averill ... be responsible for leading all financial operations and implementing key business strategies to ...
(Date:8/12/2020)... (PRWEB) , ... August 11, 2020 , ... ... a year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network ... 2021 and 2022. The network is a consortium of academic research centers in ...
(Date:8/3/2020)... ... August 03, 2020 , ... ERT, the ... CEO has been named one of the 100 most inspiring individuals in the ... honorees are selected based on how they have inspired their colleagues and affected ...
(Date:7/31/2020)... ... July 29, 2020 , ... Diversified Technologies, Inc. has ... be configured to drive Klystrons, TWTs, IOTs, and magnetrons. , DTI Radar ... switches in a push-pull configuration; yielding fast fall time for a capacitive load. ...
Breaking Biology Technology:
(Date:7/1/2020)... , ... July 01, 2020 , ... ... awareness and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced today ... JD, PhD. Senior Fellows are charged with supporting the organization’s initiatives and overall ...
(Date:6/25/2020)... MANSFIELD, Mass. (PRWEB) , ... June 24, 2020 ... ... provider of cloud-based enterprise software and software-driven clinical data services that accelerate drug ... trials for low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. ...
(Date:6/23/2020)... ... June 22, 2020 , ... The field of quantitation of ... assays (LBA) have dominated this area. However, the use of mass spectrometry in this ... now necessitates the question “How do you choose which approach to use (LBA or ...
Breaking Biology News(10 mins):